Healthcare
Live Price
Offline$4.52
-1.74% today
Window Change
-23.05%
Window
May 29, 2026 → Jun 22, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 16 bars · May 29, 2026 → Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Immuneering Corporation (IMRX) is a Healthcare stock with a market cap of $190.00M and listed on NASDAQ. The stock last traded around $4.52 and down 23.1% across the available one-year price window (May 29, 2026 → Jun 22, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +37.7%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +37.7%, free cash flow +17.4% with operating margin 0.0% and ROIC -26.7%. Stock Foundry combines IMRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
IMRX
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
IMRX Max Drawdown
-32.06%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for IMRX and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.